According to a new study, those who use marijuana for therapeutic purposes are more likely to report consuming it to address symptoms such as anxiety, insomnia, chronic pain and depression. The study, titled Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population,” was published in the Journal of General Internal Medicine and first reported on by NORML.

Research shows CBD adjusts the brain’s serotonin levels, helping those with depression stabilize mood, attention, and other symptoms.

Depression doesn’t confront its patients. Often, it sneaks up, surprises, or stuns. Depression makes it difficult to work, focus on relationships, and enjoy social activities. Those with depression typically receive antidepressant prescriptions from doctors, but unpredictable side effects and personal preference means these drugs aren’t for everyone.

What about cannabidiol (CBD)? Because some channels promote CBD as a cure-all for every ailment under the sun, using it to treat mental illness seems dubious. But as research explains, there is scientific explanations for how CBD can positively impact patients with depression.

Although clinical research on CBD and diabetes is still limited, many people use CBD oil to ease the symptoms of their disease as well as the whole host of diabetes-triggered conditions such as hypertension, pancreatic inflammation, and chronic pain.

There are certain areas that we may consider “well-studied” with regards to using CBD for diabetes, but some of them require more research due to unclear results from past studies.

Then, there’s the question that troubles the majority of new consumers: where do you buy high-quality CBD oil to safely manage the symptoms of diabetes?

Colorado State University researchers found that CBD caused cell death in glioblastoma, a rare and intractable form of brain cancer.

Green Horizons, a consumer insights firm for the cannabis space, released a detailed 42-page report exploring the “attitudes, usage, and market potential for cannabis and cannabis products.” 

The study revealed that many of the stereotypes commonly associated with cannabis users are not as true as society once believed. The firm followed 1,100 U.S. adults over the age of 18, with an oversample of cannabis users to match their true proportion in the population. 

According to the report, cannabis users typically make as much money as non-users, with $59.7k representing users and $57.5k for non-users. This demolishes the myth that cannabis users are automatically lazy, with no drive or motivation to be successful. 

A new study has “confirmed that the therapeutic benefit of cannabinoids may extend beyond spasticity, improving spasticity-related symptoms even in non-NRS responder patients”. The study, titled Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study, was published in the journal Neurological Sciences

A CAD $1.5 million grant has been awarded by the Canadian Institutes of Health Research’s Institute of Cancer Research and the Canadian Cancer Society to look into the use of medical cannabis in children with cancer.

The study, called C4T (Canadian Childhood Cannabinoid Clinical Trials), will be led by the Rady Faculty of Health Sciences at the University of Manitoba.

According to a new study, men who report having consumed marijuana in the past year possess elevated levels of testosterone as compared to non-users. The study, titled The effect of tetrahydrocannabinol on testosterone among men in the United States: Results from the National Health and Nutrition Examination Survey, was published in the World Journal of Urology.

For the study researchers from the University of Chicago, the University of Miami, and John Hopkins University in Baltimore assessed the relationship between past-year marijuana use and testosterone levels in a cohort of self-reported cannabis consumers.

According to a new study first reported on by NORML and published in the journal Discoveries, the daily administration of whole-plant cannabis oil is associated with a significant improvement in symptoms of anxiety and vertigo.

Is there anything more divisive than medical cannabis? 

Not for Dr. Michael Verbora, chief medical officer at Aleafia Health. Through private clinics Canabo and GrowWise, he and a team of physicians and nurse practitioners meet with Canadians who, despite having a diverse set of medical conditions, often come looking for the same thing.